Sleep Habits and Disorders in School-Aged Children: A Cross-Sectional Study Based on Parental Questionnaires
Abstract
Sleep is a crucial physiological process for cognitive, emotional, and physical development during childhood. Despite its importance, a significant percentage of school-aged children experience sleep disturbances, which can impact academic performance and overall well-being. This cross-sectional study aims to investigate sleep habits and disorders in children aged 6–13 years, identifying issues such as difficulties falling asleep, frequent awakenings, and parasomnias, as well as their correlations with daytime consequences. Methods: A structured questionnaire, based on the Sleep Disturbance Scale for Children (SDSC), was administered to 100 parents of school-aged children. The sample included participants without diagnosed neurological disorders, neurodevelopmental disorders, or chronic illnesses interfering with sleep. The data were statistically analyzed to assess the frequency and severity of sleep disturbances and their correlations with daytime symptoms. Results: Although most children (44.1%) slept 8–9 h per night, 32.4% exhibited bedtime resistance, and 29.4% had difficulty falling asleep. Common sleep disturbances included occasional snoring (44.1%), bruxism (11.8%), morning fatigue (41.2%), and daytime sleepiness (15.2%). Additionally, 23.5% of the children experienced confusion upon waking. The analysis also revealed a correlation between sleep fragmentation and mood alterations or cognitive difficulties. Conclusions: The study confirms the high prevalence of sleep…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.